• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Iron homeostasis in the liver.肝脏中的铁稳态。
Compr Physiol. 2013 Jan;3(1):315-30. doi: 10.1002/cphy.c120016.
2
The Role of Iron and Iron Overload in Chronic Liver Disease.铁及铁过载在慢性肝病中的作用
Med Sci Monit. 2016 Jun 22;22:2144-51. doi: 10.12659/msm.896494.
3
Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.肝硬化中铁过载的分子发病机制及临床后果
Hepatobiliary Pancreat Dis Int. 2016 Oct;15(5):461-479. doi: 10.1016/s1499-3872(16)60135-2.
4
An ellagic acid isolated from Clerodendrum viscosum leaves ameliorates iron-overload induced hepatotoxicity in Swiss albino mice through inhibition of oxidative stress and the apoptotic pathway.从海桐叶中分离得到的鞣花酸通过抑制氧化应激和凋亡途径改善瑞士白化小鼠的铁过载肝毒性。
Biomed Pharmacother. 2018 Oct;106:454-465. doi: 10.1016/j.biopha.2018.06.133. Epub 2018 Jul 11.
5
Overview of iron metabolism in health and disease.健康与疾病状态下铁代谢概述。
Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S6-S20. doi: 10.1111/hdi.12542. Epub 2017 Mar 15.
6
Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.肝特异性β-catenin 缺失的小鼠在铁过载后会发生脂肪性肝炎和肝纤维化。
J Hepatol. 2017 Aug;67(2):360-369. doi: 10.1016/j.jhep.2017.03.012. Epub 2017 Mar 22.
7
Effects of iron overload on chronic metabolic diseases.铁过载对慢性代谢性疾病的影响。
Lancet Diabetes Endocrinol. 2014 Jun;2(6):513-26. doi: 10.1016/S2213-8587(13)70174-8. Epub 2013 Dec 30.
8
Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle.小鼠肝脏铁过载的蛋白质组学分析表明尿素循环失调、脂肪酸氧化受损以及甲基化循环发生变化。
Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1490-8. doi: 10.1152/ajpgi.00455.2006. Epub 2007 Feb 15.
9
Liver iron sensing and body iron homeostasis.肝脏铁感应与体内铁稳态。
Blood. 2019 Jan 3;133(1):18-29. doi: 10.1182/blood-2018-06-815894. Epub 2018 Nov 6.
10
Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload.白藜芦醇在铁过载的获得性和遗传性小鼠模型中介导肝脏治疗作用。
Liver Int. 2016 Feb;36(2):246-57. doi: 10.1111/liv.12893. Epub 2015 Jul 3.

引用本文的文献

1
Metals in the human liver: An underappreciated risk factor of hepatic insulin resistance and associated pathophysiology.人体肝脏中的金属:肝脏胰岛素抵抗及相关病理生理学中一个未得到充分认识的危险因素。
Environ Pollut. 2025 Jul 17;383:126844. doi: 10.1016/j.envpol.2025.126844.
2
Meat consumption and risk of hepatobiliary cancers in the National Institutes of Health-AARP Diet and Health Study.美国国立卫生研究院-美国退休人员协会饮食与健康研究中的肉类消费与肝胆癌风险
JNCI Cancer Spectr. 2025 Jul 1;9(4). doi: 10.1093/jncics/pkaf068.
3
A dedicated phantom for exploring the interplay of fat and paramagnetic substances in quantitative susceptibility mapping.一种用于在定量磁化率成像中探究脂肪和顺磁性物质相互作用的专用体模。
MAGMA. 2025 Jun 2. doi: 10.1007/s10334-025-01261-3.
4
Iron acquisition strategies in pathogenic fungi.致病真菌中的铁获取策略。
mBio. 2025 Jun 11;16(6):e0121125. doi: 10.1128/mbio.01211-25. Epub 2025 May 20.
5
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease.与HFE相关的血色素沉着症可能是一种原发性库普弗细胞疾病。
Biomedicines. 2025 Mar 10;13(3):683. doi: 10.3390/biomedicines13030683.
6
L-Arginine and Nitric Oxide in Vascular Regulation-Experimental Findings in the Context of Blood Donation.血管调节中的L-精氨酸与一氧化氮——献血背景下的实验发现
Nutrients. 2025 Feb 13;17(4):665. doi: 10.3390/nu17040665.
7
Protective effects of Pyrogallol and Caffeic acid against Fe -Ascorbate-induced oxidative stress in the wistar rats liver: An in vitro study.连苯三酚和咖啡酸对Wistar大鼠肝脏中铁-抗坏血酸诱导的氧化应激的保护作用:一项体外研究。
Heliyon. 2025 Feb 7;11(3):e42518. doi: 10.1016/j.heliyon.2025.e42518. eCollection 2025 Feb 15.
8
Iron-Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus.缺铁性贫血增加2型糖尿病患者患糖尿病肾病的风险。
J Diabetes. 2025 Feb;17(2):e70060. doi: 10.1111/1753-0407.70060.
9
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.非酒精性脂肪性肝病中的铁代谢:一个有前景的治疗靶点。
Liver Res. 2022 Sep 19;6(4):203-213. doi: 10.1016/j.livres.2022.09.003. eCollection 2022 Dec.
10
Dietary Fe-Gly supplementation attenuates enterotoxigenic (ETEC)-induced inflammation response and intestinal barrier dysfunction in piglets.日粮补充甘氨酸铁可减轻仔猪产肠毒素大肠杆菌(ETEC)诱导的炎症反应和肠道屏障功能障碍。
Front Vet Sci. 2025 Jan 29;12:1537604. doi: 10.3389/fvets.2025.1537604. eCollection 2025.

本文引用的文献

1
Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.亚铁转运蛋白的 hepcidin 诱导内吞作用依赖于亚铁转运蛋白的泛素化。
Cell Metab. 2012 Jun 6;15(6):918-24. doi: 10.1016/j.cmet.2012.03.018.
2
Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT.亚铁转运蛋白内化的铁调素介导的分子机制需要亚铁转运蛋白赖氨酸,而不是酪氨酸或 JAK-STAT。
Cell Metab. 2012 Jun 6;15(6):905-17. doi: 10.1016/j.cmet.2012.03.017.
3
Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice.肝细胞和巨噬细胞中的 Ferroportin1 对于小鼠体内铁储存的有效动员是必需的。
Hepatology. 2012 Sep;56(3):961-71. doi: 10.1002/hep.25746. Epub 2012 Aug 2.
4
Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling.小鼠β地中海贫血中血浆铁调素表达降低与骨形态发生蛋白/信号转导和转录激活因子信号的抑制有关。
Blood. 2012 Mar 29;119(13):3187-9. doi: 10.1182/blood-2012-01-405563.
5
Macrophages and systemic iron homeostasis.巨噬细胞与全身铁稳态。
J Innate Immun. 2012;4(5-6):446-53. doi: 10.1159/000336423. Epub 2012 Mar 21.
6
Molecular diagnostic and pathogenesis of hereditary hemochromatosis.遗传性血色素沉着症的分子诊断与发病机制
Int J Mol Sci. 2012;13(2):1497-1511. doi: 10.3390/ijms13021497. Epub 2012 Feb 1.
7
Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis.鉴定出日本青少年血色病男性患者 HAMP 基因中的一种新突变,导致无法检测到亚铁调素分子。
Blood Cells Mol Dis. 2012 Mar 15;48(3):179-82. doi: 10.1016/j.bcmd.2012.01.002. Epub 2012 Jan 30.
8
Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.针对 hepcidin-ferroportin 轴开发治疗慢性病贫血和炎症性贫血的新策略。
Am J Hematol. 2012 Apr;87(4):392-400. doi: 10.1002/ajh.23110. Epub 2012 Jan 31.
9
Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.肝缺氧诱导因子-2 通过增加红细胞生成来下调小鼠肝组织中血红素的表达。
Haematologica. 2012 Jun;97(6):827-34. doi: 10.3324/haematol.2011.056119. Epub 2011 Dec 29.
10
The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders.亚铁血红素-铁蛋白系统作为贫血症和铁过载疾病的治疗靶点。
Hematology Am Soc Hematol Educ Program. 2011;2011:538-42. doi: 10.1182/asheducation-2011.1.538.

肝脏中的铁稳态。

Iron homeostasis in the liver.

机构信息

Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Compr Physiol. 2013 Jan;3(1):315-30. doi: 10.1002/cphy.c120016.

DOI:10.1002/cphy.c120016
PMID:23720289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3936199/
Abstract

Iron is an essential nutrient that is tightly regulated. A principal function of the liver is the regulation of iron homeostasis. The liver senses changes in systemic iron requirements and can regulate iron concentrations in a robust and rapid manner. The last 10 years have led to the discovery of several regulatory mechanisms in the liver that control the production of iron regulatory genes, storage capacity, and iron mobilization. Dysregulation of these functions leads to an imbalance of iron, which is the primary cause of iron-related disorders. Anemia and iron overload are two of the most prevalent disorders worldwide and affect over a billion people. Several mutations in liver-derived genes have been identified, demonstrating the central role of the liver in iron homeostasis. During conditions of excess iron, the liver increases iron storage and protects other tissues, namely, the heart and pancreas from iron-induced cellular damage. However, a chronic increase in liver iron stores results in excess reactive oxygen species production and liver injury. Excess liver iron is one of the major mechanisms leading to increased steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma.

摘要

铁是一种必需的营养物质,其含量受到严格调控。肝脏的主要功能之一是调节铁的动态平衡。肝脏可以感知全身铁需求的变化,并以强大而迅速的方式调节铁浓度。过去 10 年的研究发现了肝脏中几个控制铁调节基因表达、储存能力和铁动员的调节机制。这些功能的失调会导致铁失衡,这是铁相关疾病的主要原因。贫血和铁过载是全球最常见的两种疾病,影响超过 10 亿人。已经鉴定出肝脏来源的基因突变,证明了肝脏在铁稳态中的核心作用。在铁过量的情况下,肝脏会增加铁的储存并保护其他组织,如心脏和胰腺免受铁诱导的细胞损伤。然而,肝脏铁储存的慢性增加会导致过量的活性氧产生和肝损伤。过多的肝脏铁是导致脂肪性肝炎、纤维化、肝硬化和肝细胞癌增加的主要机制之一。